Chimeric antigen receptor modified T-cells for cancer treatment

por Han, Xiao, Wang, Yao, Han, Wei-Dong
Publicado 2018

The macrodomain family: Rethinking an ancient domain from evolutionary perspectives

por Li, XiaoLei, Wu, ZhiQiang, Han, WeiDong
Publicado 2013

Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report

por Zhai, Chong-Ya, Yin, Lu-Xi, Han, Wei-Dong
Publicado 2022

Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer

por Wu, Zhuo-Xuan, Liu, Zhen, Jiang, Han-Ling, Pan, Hong-Ming, Han, Wei-Dong
Publicado 2016

Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials

por Zhang, Wen-ying, Liu, Yang, Wang, Yao, Wang, Chun-meng, Yang, Qing-ming, Zhu, Hong-li, Han, Wei-dong
Publicado 2017

Upregulation of CC Chemokine Receptor 7 (CCR7) Enables Migration of Xenogeneic Human Adipose-Derived Mesenchymal Stem Cells to Rat Secondary Lymphoid Organs

por Ma, Tian, Luan, Shao-Liang, Huang, Hong, Sun, Xing-Kun, Yang, Yan-Mei, Zhang, Hui, Han, Wei-dong, Li, Hong, Han, Yan
Publicado 2016

Genetically engineered T cells for cancer immunotherapy

por Li, Dan, Li, Xue, Zhou, Wei-Lin, Huang, Yong, Liang, Xiao, Jiang, Lin, Yang, Xiao, Sun, Jie, Li, Zonghai, Han, Wei-Dong, Wang, Wei
Publicado 2019

Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma

por Feng, Kai-chao, Guo, Ye-lei, Liu, Yang, Dai, Han-ren, Wang, Yao, Lv, Hai-yan, Huang, Jian-hua, Yang, Qing-ming, Han, Wei-dong
Publicado 2017

Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy

por Zhang, Yajing, Wang, Jin, Wang, Yao, Lu, Xue-Chun, Fan, Hui, Liu, Yang, Zhang, Yan, Feng, Kai-Chao, Zhang, Wen-Ying, Chen, Mei-Xia, Fu, Xiaobing, Han, Wei-Dong
Publicado 2013

The Four-Herb Chinese Medicine ANBP Enhances Wound Healing and Inhibits Scar Formation via Bidirectional Regulation of Transformation Growth Factor Pathway

por Hou, Qian, He, Wen-Jun, Hao, Hao-Jie, Han, Qing-Wang, Chen, Li, Dong, Liang, Liu, Jie-Jie, Li, Xiang, Zhang, Ya-Jing, Ma, Ying-Zhi, Han, Wei-Dong, Fu, Xiao-Bing
Publicado 2014

Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report

por Zhang, Wen-ying, Wang, Yao, Guo, Ye-lei, Dai, Han-ren, Yang, Qing-ming, Zhang, Ya-jing, Zhang, Yan, Chen, Mei-xia, Wang, Chun-meng, Feng, Kai-chao, Li, Su-xia, Liu, Yang, Shi, Feng-xia, Luo, Can, Han, Wei-dong
Publicado 2016